Abstract
Antimycotic chemotherapy for deep-seated candidosis in patients with reduced immune-defense is still a problem. Only a few antimycotics are available for systemic use and all have their limitations. Thus, interest in drug combinations is increasing in the hope of improving the efficacy and the spectrum of antimycotic therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Rererences
A. Polak, H.J. Scholer, M. Wall, Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice, Chemotherapy, 28: 461 (1982).
A. Polak: Synergism of polyene antibiotics with 5-fluorocytosine, Chemotherapy, 24: 2 (1978).
A. Polak,: Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice, Chemotherapy, 33: 381 (1987).
A. Polak, 5- Fluorocytosine et associations, Ann.Biol.Clin., 45: 669 (1987).
A. Polak and A. Schaffner, Association des antifongiques dans les mycoses experimentales, Med.Mal.Inf., 14: 553 (1980).
A. Schaffner and P.G. Frick, The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis, J.Infect.Dis., 151: 902 (1985).
J.E. Bennett, W.E. Dismukes, R.J. Duma, G. Medoff, M.A. Sande et al., A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, New Engl. J.Med., 301: 127 (1979).
A. Polak, Combined therapy of systematic mycoses, in: Proc. 13th Intern. Congr. Chemother., Vienna 1983, K.H.Spitzy and K.Karrer, eds., Symposia 49/1 and 49/2, part 20, pp. 2–9, H.Egermann, Vienna (1983).
J.E. Bennett, R.M. Kliegman, A.A. Fanaroff, Disseminated fungal infections in very lowbirth-weight infants: therapeutic toxicity, Pediatrics, 73: 153 (1984).
R.G. Faix, Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement, J.Pediatr., 105: 616 (1984).
D. Armstrogn, Problems in the management of opportunistic fungal infections, 9th Ian Murray Memorial Lecture, Brit.Soc.Mycopathol. (1986).
J.W.M. Gold, Opportunistic fungal infections in patients with neo-plastic disease, Am.J.Med., 76: 458 (1984).
E. Haron, R. Feld, P. Tuffnell, B. Patterson, R. Hasselback, A. Matlow, Hepatic candidiasis: an increasing problem in immunocompromised patients, Am.J.Med., 83: 17 (1987).
D. Dupont and E.E. Drouhet, Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts, new clinical and therapeutic aspects in 38 patients. J.Infect.Dis., 152: 577 (1985).
M.A. Viviani and A.M. Tortorano, Management of cryptococcosis in AIDS patients, Xth Congr. ISHAM, Barcelona 1988, poster N.RT17–1.
D. Borelli, A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis, Rev.Infect.Dis., 9 (Suppl. 1) 557 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Polak, A. (1991). Combination Therapy in Experimental and Clinical Candidosis. In: Tümbay, E., Seeliger, H.P.R., Anǧ, Ö. (eds) Candida and Candidamycosis. Federation of European Microbiological Societies Symposium Series, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5910-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5910-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5912-8
Online ISBN: 978-1-4684-5910-4
eBook Packages: Springer Book Archive